+
Site Tour
CARDIAC
RESYNCHRONIZATION
THERAPY DEVICES

Cardiac resynchronization therapy (CRT) is a proven
clinical treatment for heart failure management.

INDICATIONS FOR USE1

CRT devices are indicated for reduction of symptoms in adult patients who have congestive heart failure, a reduced left ventricular ejection fraction (LVEF) and a prolonged QRS duration.

CRT defibrillator (CRT-D) devices are indicated in adult patients who meet the CRT indications and have already survived a cardiac arrest or are at a high risk of sudden cardiac death (SCD) due to ventricular tachycardia (VT) or ventricular fibrillation (VF).*

CRT-Ds are most commonly implanted within a device pocket in the pectoral region.

*CRT-D devices have not been tested in pediatric patients.

LEARN MORE ABOUT:

2021 ESC GUIDELINES HEART FAILURE eIFU

Connext
Hub

Your ‘go to’ resource for the most up-to-date information on cardiovascular conditions and stroke prevention technologies, developed in partnership with physicians and tailored to your personal preferences.

Find out more

 

TV

References
  1. Avant™, Neutrino™ NxT, Gallant™, Entrant™ Manual. ARTEN600342965_C. February 20, 2026.
  2. Varma N, Boehmer J, Bhargava K, et al. Evaluation, Management, and Outcomes of Patients Poorly Responsive to Cardiac Resynchronization Device Therapy. J Am Coll Cardiol. 2019;74(21):2588-2603. doi: 10.1016/j.jacc.2019.09.043.
  3. R Rickard J, Cheng A, Spragg D, et al. Durability of the survival effect of cardiac resynchronization therapy by level of left ventricular functional improvement: fate of “nonresponders”. Heart Rhythm. 2014;11(3):412-6. doi: 10.1016/j.hrthm.2013.11.025. 
  4. Varma N, Auricchio A, Connolly AT, et al. The cost of non-response to cardiac resynchronization therapy: characterizing heart failure events following cardiac resynchronization therapy. Europace. 2021;23(10):1586-1595. doi: 10.1093/europace/euab123. 
  5. Chung ES, Leon AR, Tavazzi L, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008;117(20):2608-16. doi: 10.1161/ CIRCULATIONAHA.107.743120. 
  6. Leclercq C, Burri H, Calò L, et al. Multipoint pacing is associated with reduction of heart failure hospitalizations or death in patients who do not respond to cardiac resynchronization therapy: results of the MORE-CRT MPP randomized trial. Europace. 2025;27(6):euaf070. doi: 10.1093/europace/euaf070. 
  7. Data compiled from clinical study results, on file in Report 60034670. 
  8. Thibault B, Dubuc M, Guerra PG, et al. Electrode selection to avoid phrenic stimulation with a quadripolar left heart lead. Heart Rhythm. 2011;8(5): S68. doi: 10.1016/j.hrthm.2011.03.023. 

™ indicates a trademark of the Abbott group of companies.

© Abbott 2026. All rights reserved. MAT-2676036 v1.0

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline